CINECA IRIS Institutional Research Information System

MACCARIO, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6571
EU - Europa 5041
AS - Asia 2626
SA - Sud America 133
OC - Oceania 75
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6376
CN - Cina 1669
IT - Italia 899
SE - Svezia 756
IE - Irlanda 587
DE - Germania 565
UA - Ucraina 532
FR - Francia 401
GB - Regno Unito 348
FI - Finlandia 310
KR - Corea 310
CA - Canada 167
PL - Polonia 147
JP - Giappone 134
AT - Austria 120
VN - Vietnam 118
BR - Brasile 84
AU - Australia 72
TR - Turchia 68
ES - Italia 67
BE - Belgio 59
GR - Grecia 53
NL - Olanda 46
TW - Taiwan 43
IN - India 42
HK - Hong Kong 38
RU - Federazione Russa 35
PH - Filippine 27
IL - Israele 21
JO - Giordania 20
MX - Messico 20
MY - Malesia 20
RO - Romania 20
MU - Mauritius 19
PT - Portogallo 19
CH - Svizzera 18
UZ - Uzbekistan 18
ID - Indonesia 17
DK - Danimarca 16
SG - Singapore 14
AR - Argentina 13
NO - Norvegia 12
CO - Colombia 10
TH - Thailandia 9
PE - Perù 8
QA - Qatar 8
SN - Senegal 8
CZ - Repubblica Ceca 7
HU - Ungheria 7
IR - Iran 7
PK - Pakistan 7
CY - Cipro 6
EC - Ecuador 6
ZA - Sudafrica 6
CL - Cile 5
BD - Bangladesh 4
EU - Europa 4
GT - Guatemala 4
KW - Kuwait 4
LB - Libano 4
BG - Bulgaria 3
DZ - Algeria 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
EE - Estonia 2
LK - Sri Lanka 2
PR - Porto Rico 2
SA - Arabia Saudita 2
SI - Slovenia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
GH - Ghana 1
KE - Kenya 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MW - Malawi 1
PS - Palestinian Territory 1
RS - Serbia 1
UG - Uganda 1
VE - Venezuela 1
Totale 14494
Salva come PNG Salva come JPEG
Città #
Beijing 1370
Chandler 1033
Dublin 574
Houston 558
Fairfield 288
Jacksonville 275
Ann Arbor 256
Medford 222
Dearborn 203
Nyköping 200
Wilmington 200
Woodbridge 184
Princeton 183
Villeurbanne 182
Redwood City 180
Milan 151
Torino 140
Ashburn 122
Warsaw 117
Vienna 112
Cambridge 94
Seattle 89
Boardman 78
Dong Ket 71
Boston 69
Verona 67
Pisa 62
Toronto 60
Brussels 52
Lachine 43
Tokyo 40
Turin 38
Norwalk 33
Taipei 29
Fremont 28
Falls Church 27
Guangzhou 27
Shanghai 26
Hangzhou 25
Nanjing 25
Mountain View 24
Hefei 23
Munich 21
Ottawa 21
London 19
Rome 19
Seoul 17
Central District 16
Cupertino 16
Detroit 15
Istanbul 15
San Diego 15
Chengdu 14
Absecon 13
Ankara 13
Duncan 13
Hebei 13
Kunming 13
Paris 13
San Mateo 13
Philadelphia 12
São Paulo 12
Kuala Lumpur 11
Menlo Park 11
Piemonte 11
Wuhan 11
Chicago 10
Moscow 10
Padova 10
Portland 10
Redmond 10
Alcalá De Henares 9
Berlin 9
Napoli 9
New York 9
Polska 9
Buenos Aires 8
Changsha 8
Düsseldorf 8
Figtree 8
Jakarta 8
Nanchang 8
Phoenix 8
Silver Spring 8
Singapore 8
Brisbane 7
Brooklyn 7
Delhi 7
Nashville 7
Rochester 7
Shenyang 7
Zhengzhou 7
Atlanta 6
Budapest 6
Dallas 6
Durham 6
Edinburgh 6
Lima 6
Los Angeles 6
Melbourne 6
Totale 8191
Salva come PNG Salva come JPEG
Nome #
Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study 2167
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 356
Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement : Diabetes mellitus and thyroid disorders: recommendations for clinical practice. 300
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 300
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas 271
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. 268
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. 239
Urinary cortisol and psychopathology in obese binge eating subjects. 222
Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. 219
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 199
Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults. 171
Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion. 166
Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans. 164
Mezzo di contrasto iodato e funzionalità tiroidea: una relazione da non sottovalutare. 155
HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease 142
Effects of meal timing on changes in circulating epinephrine, norepinephrine, and acylated ghrelin concentrations: A pilot study 135
PERCORSO DIAGNOSTICOTERAPEUTICO ASSISTENZIALE DELLE MALATTIE TIROIDEE 126
Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. 124
Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. 120
Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. 116
Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. 110
Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man. 109
Diagnosis of GH deficiency in adults. 105
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 102
Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus. 99
Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus. 98
Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus. 97
68 Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease 97
Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity. 95
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 95
Management of renal cancer in a contemporary series of patients affected by Von Hippel-Lindau disease. 95
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. 93
Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus. 92
Differential expressed proteins in urine samples from Von Hippel-Lindau disease and renal cell carcinoma patients versus healthy people. 92
[Neuroregulation of GH secretion in aging] 91
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease. 89
Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children. 88
Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy. 88
Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? 87
Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity. 86
Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. 80
Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. 80
Interaction of free fatty acids and arginine on growth hormone secretion in man. 80
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. 79
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 79
Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man. 77
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. 76
Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients 76
Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy 76
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. 76
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 75
Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus–pituitary disease 74
Ageing, growth hormone and physical performance. 74
Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. 74
Pituitary-gonadal function in males with Down’s syndrome. 74
Biologic activities of growth hormone secretagogues in humans. 73
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. 73
Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans. 72
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 71
Age-related endocrine and metabolic changes in simple obesity. 71
Concomitant impairment of GH secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome 70
Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement 70
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. 69
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients 69
DIFFERENT ENDOCRINE-METABOLIC ABNORMALITIES BETWEEN “PURE” 45,XO TURNER’S SYNDROME AND MOSAICS 69
SENSITIVITY AND SPECIFICITY OF DIFFERENT PROVOCATIVE TESTS ASSESSING THE FUNCTION OF HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS SUSPECTED FOR SECONDARY HYPOADRENALISM 69
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 69
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 68
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 68
Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes. 65
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 65
[Growth hormone and lipids] 64
ADULT PATIENTS WITH DOWN’S SYNDROME SHOW ENHANCED BASAL TSH LEVELS BUT NORMAL TSH RESPONSE TO TRH 64
Low dose orally administered arginine is able to enhance both basLow dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. 64
Chronic treatment with pirenzepine decreases growth hormone secretion in insulin-dependent diabetes mellitus. 63
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index 63
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 63
Comparisons among old and new provocative tests of GH secretion in 178 normal adults. 62
Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. 62
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 62
Incidenza di alterazioni tiroidee dopo coronarografia con mezzo di contrasto iodato. 62
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study 62
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients 61
The inhibitory effect of glucose on growth hormone secretion is lost in obesity but not in hypertension. 60
Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study 60
Diagnostica neuroendocrina del paziente obeso (alterazioni neuroendocrine nel paziente obeso) 58
L-Arginine 58
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 58
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the tyhrotroph and lactotroph function 57
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity. 56
Primary pigmented micronodular disease of the adrenals. 56
Obstructive sleep apnea syndrome impairs insulin sensitivity independently of anthropometric variables 56
ENDOCRINE DISORDERS 56
Treating with liraglutide an obese patient with type 2 diabetes mellitus and hereditary hemochromatosis 56
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 55
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. 54
Ghrelin and other gastrointestinal peptides involved in the control of food intake 54
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. 53
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. 53
Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status 53
Totale 11834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27015
article - articoli 0
book - libri 0
conference - conferenze 2054
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201887 0000 00 00 00087
2018/20191647 5853220101 101214 83170 112144268123
2019/20202465 10789183220 251536 243161 23817916494
2020/20211965 148117177100 243125 176102 222193129233
2021/20221928 7087101106 11692 142119 99224330442
2022/20233054 34021767347 312744 263194 332821560
Totale 15051